Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Germany / NCT06294405
Recruiting Observational

Intraocular Lens Implant Registry Study

NCT06294405 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2024-02-21
Last updated
2024-03-05

Condition(s) studied

Intraocular Lens ComplicationIntraocular Lens RotationIntraocular Lens Associated Postoperative InflammationLens Opacities

Investigational drug(s) / intervention(s)

Intraocular lens Implantation

Intraocular lens Implantation: Intraocular lenses are implanted during cataract surgery to replace the human crystalline lens.

Study summary

The goal of this registry study is to optimize the results with intraocular lens implants used in cataract surgery.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: Treatment with an intraocular lens implant 18 years of age or older Patient consent Full legal capacity Exclusion Criteria: Dementia Pregnancy Breastfeeding

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University Hospital Augsburg Augsburg Germany Recruiting

More University Hospital Augsburg trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06294405 on ClinicalTrials.gov ↗ ← All trials in Germany